Skip to content
Aenova

Aenova

Pharma·Germany·Exited 2024·Held 12yr
Entry
2012
Hold
12yr
Exit
2024

Who owns Aenova?

Aenova was owned by BC Partners through BC European Capital IX (2012 vintage) from 2012 to 2024, exited via Trade Sale. Across its history, Aenova has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-04-21

BC Partners
Most recent investor
BC Partners
BC European Capital IX · 2012 · Buyout
2 ownership periods · full history below

Key facts

HQUK
SectorPharma
Key takeaways
  • ·Fully exited in 2024.
  • ·Average hold across 2 realized cycles: 10 years.

Ownership history

2 ownership periods

Exited
Last exited in 2024 to .
Bridgepoint
BridgepointExited 2012
2005 · 2012(7yr) · Europe VII (BE VII) · 2022 · Buyout
Secondary · to
MOIC
BC Partners
BC PartnersExited 2024
2012 · 2024(12yr) · BC European Capital IX · 2012 · Buyout
Trade Sale · to
MOIC
Track Aenova

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Aenova?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Aenova.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue